SEMA3A and esophageal squamous cell carcinoma: Overexpression of SEMA3A promotes tumor progression and predicts poor prognosis of patients with hepatocellular carcinoma after curative resection [50], consistent with its similar effect on OS of patients with ESCC in the present study.